0001179110-20-011277.txt : 20201120
0001179110-20-011277.hdr.sgml : 20201120
20201120182546
ACCESSION NUMBER: 0001179110-20-011277
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201120
FILED AS OF DATE: 20201120
DATE AS OF CHANGE: 20201120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LaBarre Michael J.
CENTRAL INDEX KEY: 0001507174
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32335
FILM NUMBER: 201333775
MAIL ADDRESS:
STREET 1: 11388 SORRENTO VALLEY ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HALOZYME THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001159036
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 880488686
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11388 SORRENTO VALLEY ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121-1345
BUSINESS PHONE: (858) 794-8889
MAIL ADDRESS:
STREET 1: 11388 SORRENTO VALLEY ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121-1345
FORMER COMPANY:
FORMER CONFORMED NAME: HALOZYME THERAPEUTICS INC
DATE OF NAME CHANGE: 20040312
FORMER COMPANY:
FORMER CONFORMED NAME: GLOBAL YACHT SERVICES INC
DATE OF NAME CHANGE: 20010912
4
1
edgar.xml
FORM 4 -
X0306
4
2020-11-20
0
0001159036
HALOZYME THERAPEUTICS, INC.
HALO
0001507174
LaBarre Michael J.
C/O HALOZYME THERAPEUTICS, INC.
11388 SORRENTO VALLEY ROAD
SAN DIEGO
CA
92121
0
1
0
0
SVP, Chief Technical Officer
Common Stock
2020-11-20
4
S
0
4111
38.244
D
142689
D
Common Stock
2020-11-20
4
S
0
7889
39.036
D
134800
D
This disposition was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person.
Represents a weighted average sales price per share. These shares were sold at prices ranging from $37.74 to $38.72. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Represents a weighted average sales price per share. These shares were sold at prices ranging from $38.75 to $39.12. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
/s/ James R. Oehler as attorney-in-fact for Michael J. LaBarre
2020-11-20